美国 · 平台与数据 · Stocktwits
MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes
Investors were awaiting full data from the late-stage trial of intismeran autogene plus Merck’s Keytruda at the European Society for Medical Oncology Congress on October 24.
在 Stocktwits 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stocktwits.com)
